Table 2 Summary of CMCINPs in this review
From: Cell membrane-camouflaged inorganic nanoparticles for cancer therapy
Type | Key features | Origin of shell material | Core material | Preparation strategy | Cargo loaded | Applications | Ref |
|---|---|---|---|---|---|---|---|
RBCM-INPs | Long circulation; Immune escape | RBC | Fe3O4 | Extrusion | / | MRI; Anti-tumor drug delivery; Hyperthermia; Tissue repair | [47] |
MNC | Sonication | Cyp | Fluorescence imaging; MRI; PTT | [38] | |||
UCNPs | Extrusion | FA | Fluorescence imaging; PDT | [49] | |||
MSNs | Extrusion | Dox/Ce6 | Fluorescence imaging; Drug delivery | [59] | |||
AuNCs | Extrusion | / | PTT | [109] | |||
MNs | Microfluidic Electroporation | / | PTT; MRI | [48] | |||
CCM-INPs | Homologous targeting; Immune escape | UM-SCC-7; H22; HeLa; COS7 | MNP | Extrusion | DOX | Drug delivery; MRI | [63] |
KB | Gold | Extrusion | / | PTT; Radiotherapy | [64] | ||
B16-F10 | H-MnO2 | Stir/Co-incubation | Ce6;GOx | PDT; Starvation therapy | [77] | ||
MSCM-INPs | Tumor-homing affinity; Easy expansion in vitro | MSC | UCNPs | Extrusion | ZnPc;MC540 | PDT | [81] |
SPIO | Sonication | STM | Drug-targeted delivery; Magnetic hyperthermia therapy; MRI | [82] | |||
WBCM-INPs | Inflammation targeting; Reducing opsonization | Macrophage | AuNS | Extrusion | / | PTT; Bio-imaging | [86] |
Leukocyte cells (THP-1) | GNS | Sonication | DOX | PTT; Drug delivery | [91] | ||
Leukocyte cells | MNC | Sonication | / | CTC detection | [96] | ||
PLTM-INPs | Low immunogenicity; Cancer targeting ability | Platelet | MNs | Extrusion | / | MRI; PTT | [32] |
AuNRs | Microfluidic Electroporation | / | PTT | [103] | |||
MOF | Extrusion | siRNA | Tumor-associated gene silencing | [104] | |||
HCM-INPs | Immune escape; Homogenous targeting | RBC/B16-F10 | CuS | Sonication | DOX | Drug delivery; PTT | [70] |
Platelet/Cancer cell/stem cell | MNs | Extrusion/Sonication | / | PTT; MRI | [108] |